Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

CWRU to establish umbrella program for integrative oncology

Case Western Reserve University School of Medicine is honored to announce gifts to establish the inaugural Parker Hannifin - Helen Moss Cancer Research Foundation Professorship in Integrative Oncology. This professorship will establish the School of Medicine and its affiliate hospitals as national leaders in teaching, research, and patient care in the field of integrative oncology.

8 Nov 2011

Top-line results from AstraZeneca and Targacept's TC-5214 Phase 3 studies on MDD

AstraZeneca and Targacept, Inc. today announced top-line results from the first of four RENAISSANCE Phase 3 studies investigating the efficacy and tolerability of TC-5214 as an adjunct therapy to an antidepressant in patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant treatment.

8 Nov 2011

EpiCept reports net loss of $5.4 million for third quarter 2011

EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2011, and provided an update with respect to the Company's key business initiatives.

8 Nov 2011

Bristol-Myers Squibb receives FDA approval for Erbitux to treat head and neck cancer

The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.

8 Nov 2011

New data from Pfizer's hematology portfolio to be presented at 53rd ASH annual meeting

Pfizer Oncology will present data on a number of investigational compounds from its hematology portfolio, including new data from bosutinib in chronic myeloid leukemia (CML), inotuzumab in non-Hodgkin lymphoma (NHL), as well as the first presentation of clinical data for PF-04449913, which inhibits Smoothened (SMO), a key component of the Hedgehog pathway.

7 Nov 2011

World leading scientists receive Cancer Research UK Prizes

Cancer Research UK yesterday announced the recipients of this year's Cancer Research UK Prizes at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.

7 Nov 2011

Just couple of glasses of wine a day could raise risk of breast cancer: Study

According to a new major study just two glasses of a wine a day can increase the risk of breast cancer among women by 50%. Researchers also warn that women who drink regularly in their 20s and 30s are far more likely to develop breast cancer in later life, regardless of whether they reduce their alcohol consumption.

7 Nov 2011

DSS VistA Chemotherapy Manager goes live at San Francisco VA Medical Center

DSS, Inc., a leading provider of software development, integration, project management, implementation and support of VistA, today announced that its customized VistA Chemotherapy Manager (VCM) system is now live and in production at the San Francisco VA Medical Center.

7 Nov 2011

Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven by the launches of several promising emerging therapies, the prostate cancer drug market will experience robust growth over the next decade, increasing from $3.6 billion in 2010 to $10.1 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

7 Nov 2011

NanoString closes $20M Series D round of equity financing

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $20 million in a Series D round of equity financing.

From NanoString Technologies 7 Nov 2011

Transgenomic and A. Menarini Diagnostics enter distribution agreement for mutation detection systems

Transgenomic, Inc. and A. Menarini Diagnostics today announced an exclusive distribution agreement for Transgenomic's SURVEYOR Scan and WAVE MCE (Micro-Capillary Electrophoresis) Mutation Detection system to its network of over 2,000 pathologists throughout Europe.

7 Nov 2011

Gifts established at Case Western Reserve to educate physicians in integrative oncology

7 Nov 2011

PKM2 enzyme has important non-metabolic functions in cancer formation

The embryonic enzyme pyruvate kinase M2 (PKM2) has a well-established role in metabolism and is highly expressed in human cancers. Now, a team led by researchers at the University of Texas MD Anderson Cancer Center reports in advance online publication of the journal Nature that PKM2 has important non-metabolic functions in cancer formation.

7 Nov 2011

Blocking APE1 enzyme could provide new way to kill cancer cells

BLOCKING a key DNA damage repair enzyme, called APE1, could provide a new way to kill cancer cells containing faulty BRCA genes, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.

7 Nov 2011

Sitting around could be waiting for cancer to strike say researchers

A new analysis reveals that more than 90,000 new cancer cases a year in the United States may be due to physical inactivity and prolonged periods of sitting. The researchers presented their findings at the annual conference of the American Institute for Cancer Research (AICR) in Washington, D.C., citing about 49,000 cases of breast cancer and 43,000 of colon cancer from over 200 studies worldwide.

6 Nov 2011

SJH&MC the first in Southeast Michigan to offer Hyperthermic Intraperitoneal Chemotherapy

A unique treatment involving the use of hot chemotherapy is being offered at St. John Hospital and Medical Center. SJH&MC is the first hospital in Southeast Michigan and one of only approximately 20 centers nationwide to offer the treatment.

5 Nov 2011

More than 36,000 people join Cancer Research UK's Voice for Radiotherapy campaign

More than 36,000 people have joined Cancer Research UK's Voice for Radiotherapy campaign to call on the government to improve radiotherapy services in England.

5 Nov 2011

NCQA recognizes three additional MetCare centers as PPC-PCMH

Metropolitan Health Networks, Inc., a leading provider of health care services in Florida, today announced that an additional three of its centers have been recognized by the National Committee for Quality Assurance (NCQA) as Physician Practice Connections - Patient-Centered Medical Homes.

5 Nov 2011

Common gut pathogen increases activity of SMO gene and causes colon tumors

Working with lab cultures and mice, Johns Hopkins scientists have found that a strain of the common gut pathogen Bacteroides fragilis causes colon inflammation and increases activity of a gene called spermine oxidase (SMO) in the intestine.

5 Nov 2011

EES closes transaction to acquire SterilMed

Ethicon Endo-Surgery, Inc. (EES), a global leader in the development of innovative medical devices for minimally invasive and open surgical procedures, today announced the closing of the transaction to acquire SterilMed, Inc. (SterilMed), a leader in the reprocessing and remanufacturing of single-use medical devices in the United States.

5 Nov 2011

Oncology News and Research

Further Reading

CWRU to establish umbrella program for integrative oncology

Top-line results from AstraZeneca and Targacept's TC-5214 Phase 3 studies on MDD

EpiCept reports net loss of $5.4 million for third quarter 2011

Bristol-Myers Squibb receives FDA approval for Erbitux to treat head and neck cancer

New data from Pfizer's hematology portfolio to be presented at 53rd ASH annual meeting

World leading scientists receive Cancer Research UK Prizes

Just couple of glasses of wine a day could raise risk of breast cancer: Study

DSS VistA Chemotherapy Manager goes live at San Francisco VA Medical Center

Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020

NanoString closes $20M Series D round of equity financing

Transgenomic and A. Menarini Diagnostics enter distribution agreement for mutation detection systems

Gifts established at Case Western Reserve to educate physicians in integrative oncology

PKM2 enzyme has important non-metabolic functions in cancer formation

Blocking APE1 enzyme could provide new way to kill cancer cells

Sitting around could be waiting for cancer to strike say researchers

SJH&MC the first in Southeast Michigan to offer Hyperthermic Intraperitoneal Chemotherapy

More than 36,000 people join Cancer Research UK's Voice for Radiotherapy campaign

NCQA recognizes three additional MetCare centers as PPC-PCMH

Common gut pathogen increases activity of SMO gene and causes colon tumors

EES closes transaction to acquire SterilMed

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News